Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

NYSE:CBNA - US15746L1008 - Common Stock

30.24 USD
+0.61 (+2.06%)
Last: 8/29/2025, 8:10:07 PM
30.24 USD
0 (0%)
After Hours: 8/29/2025, 8:10:07 PM
Fundamental Rating

4

Overall CBNA gets a fundamental rating of 4 out of 10. We evaluated CBNA against 395 industry peers in the Banks industry. CBNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CBNA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CBNA had positive earnings in the past year.
CBNA had a positive operating cash flow in the past year.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.48%, CBNA belongs to the top of the industry, outperforming 90.08% of the companies in the same industry.
CBNA has a better Return On Equity (13.65%) than 96.69% of its industry peers.
Industry RankSector Rank
ROA 1.48%
ROE 13.65%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 37.93%, CBNA belongs to the top of the industry, outperforming 94.91% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for CBNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 37.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBNA has more shares outstanding
There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC10.25%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.05% over the past year.
The Revenue has grown by 70.68% in the past year. This is a very strong growth!
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.88%
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.12%

3.2 Future

CBNA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.94% yearly.
Based on estimates for the next years, CBNA will show a quite strong growth in Revenue. The Revenue will grow by 13.62% on average per year.
EPS Next Y-27.73%
EPS Next 2Y-1.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.51%
Revenue Next 2Y13.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CBNA is valuated reasonably with a Price/Earnings ratio of 8.00.
CBNA's Price/Earnings ratio is rather cheap when compared to the industry. CBNA is cheaper than 94.15% of the companies in the same industry.
CBNA is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.27, the valuation of CBNA can be described as very cheap.
90.08% of the companies in the same industry are more expensive than CBNA, based on the Price/Forward Earnings ratio.
CBNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.72.
Industry RankSector Rank
PE 8
Fwd PE 7.27
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 12.13
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.94%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (8/29/2025, 8:10:07 PM)

After market: 30.24 0 (0%)

30.24

+0.61 (+2.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-27 2025-10-27
Inst Owners46.13%
Inst Owner Change5.35%
Ins Owners24.94%
Ins Owner Change0%
Market Cap198.37M
Analysts80
Price Target30.6 (1.19%)
Short Float %4.35%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.84%
Min EPS beat(2)30.3%
Max EPS beat(2)53.38%
EPS beat(4)4
Avg EPS beat(4)37.41%
Min EPS beat(4)5.17%
Max EPS beat(4)60.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.99%
Min Revenue beat(2)6.78%
Max Revenue beat(2)25.2%
Revenue beat(4)4
Avg Revenue beat(4)14.55%
Min Revenue beat(4)6.78%
Max Revenue beat(4)25.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.27%
PT rev (3m)1.12%
EPS NQ rev (1m)10.1%
EPS NQ rev (3m)19.13%
EPS NY rev (1m)17.65%
EPS NY rev (3m)17.65%
Revenue NQ rev (1m)8.54%
Revenue NQ rev (3m)-7.76%
Revenue NY rev (1m)8.89%
Revenue NY rev (3m)8.89%
Valuation
Industry RankSector Rank
PE 8
Fwd PE 7.27
P/S 3.51
P/FCF 12.13
P/OCF 10.45
P/B 1.26
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)3.78
EY12.5%
EPS(NY)4.16
Fwd EY13.76%
FCF(TTM)2.49
FCFY8.24%
OCF(TTM)2.89
OCFY9.57%
SpS8.61
BVpS23.93
TBVpS23.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 13.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 37.93%
GM N/A
FCFM 28.95%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 547.4%
Cap/Sales 4.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 76.34%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.88%
EPS Next Y-27.73%
EPS Next 2Y-1.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.12%
Revenue Next Year8.51%
Revenue Next 2Y13.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A